Androgen Deprivation Therapy News and Research

RSS
Research: Men who lack HSD17B4 gene may be more susceptible to treatment-resistant prostate cancer

Research: Men who lack HSD17B4 gene may be more susceptible to treatment-resistant prostate cancer

Two new treatments may benefit patients with high risk prostate cancer, trial shows

Two new treatments may benefit patients with high risk prostate cancer, trial shows

Moffitt researchers develop novel drug that may help combat castration-resistant prostate cancer

Moffitt researchers develop novel drug that may help combat castration-resistant prostate cancer

Study explores effects of androgen deprivation therapy on overall geriatric health

Study explores effects of androgen deprivation therapy on overall geriatric health

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients

Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients

Combined treatment regimen shows early promise in eliminating metastatic prostate cancer

Combined treatment regimen shows early promise in eliminating metastatic prostate cancer

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

New analysis shows correlation between testosterone-lowering therapy for prostate cancer and dementia

New analysis shows correlation between testosterone-lowering therapy for prostate cancer and dementia

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Combination therapy that targets immune-busting cells effective in treating advanced prostate cancer

Combination therapy that targets immune-busting cells effective in treating advanced prostate cancer

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

Roswell Park researchers identify gene signatures that may help predict fatal prostate cancers

Roswell Park researchers identify gene signatures that may help predict fatal prostate cancers

Common hormone therapy to treat prostate cancer may increase dementia risk in men

Common hormone therapy to treat prostate cancer may increase dementia risk in men

African-American men treated with ADT for prostate cancer suffer from high mortality rates

African-American men treated with ADT for prostate cancer suffer from high mortality rates

Study finds evidence that PD-1 antibody may benefit men with metastatic prostate cancer

Study finds evidence that PD-1 antibody may benefit men with metastatic prostate cancer

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Vanderbilt physicians examine risk factors for cardiovascular disease in prostate cancer survivors

Vanderbilt physicians examine risk factors for cardiovascular disease in prostate cancer survivors

Docetaxel remains effective in prostate cancer even after treatment with androgen-deprivation therapy

Docetaxel remains effective in prostate cancer even after treatment with androgen-deprivation therapy